Early measures
Grip strength, spirometry (“vital capacity”) and VO₂ max — the first tools to quantify how the body ages.1
The Science
Ageing is now something we can quantify, monitor, and change. The published science has moved from preventing early death to extending healthspan and supporting healthier biological ageing — read through the same twelve hallmarks, epigenetic clocks, and organ-level phenotyping that Clinic82 practises every day.
The big picture
Global life expectancy rose from roughly 47 years in 1900 to 73.6 in 2022. But quantity is not quality — the average person now spends nearly a decade in poor health. The frontier has shifted from preventing early death to extending healthspan and supporting healthier biological ageing.
Sources · ONS Healthy Life Expectancy, UK, 2022–2024 · Health Foundation, April 2026 · IHME Global Burden of Disease 2024 · Columbia Mailman, Public Health 4.0 2025.
Measuring ageing
Chronological age is a poor predictor of how you will age. Biological age — read through epigenetic clocks, plasma proteomics and metabolic markers — is more accurate and, critically, modifiable.
Grip strength, spirometry (“vital capacity”) and VO₂ max — the first tools to quantify how the body ages.1
Framingham, Gail Model, CHA₂DS₂-VASc, QRISK and SCORE — event-based risk algorithms for heart disease, breast cancer and stroke.2
Lifespan/disease-prediction tests offer lifespan prediction, but are limited as they are unable to measure actual biological ageing in the body well.3
Imaging, device and biosample markers that change with age, measured across the 82 organ types and combined with existing disease and lifespan predictors.4
1 Grip strength (Adolphe Quetelet, 1835); spirometry (John Hutchinson, 1846); VO₂ max (Archibald Hill, 1923).
2 Framingham risk score (1976) for heart disease; Gail Model (1989) for breast cancer; CHA₂DS₂-VASc (2010) for stroke risk; QRISK1–3 and SCORE for heart disease.
3 Lee-Schonberg Index, Life Insurance Tables, Suemoto Index, Horvath’s Clock, GrimAge, LinAge2, Levine PhenoAge blood panel.
4 Zolman Clocks methodology developed with Dr Oliver Zolman.
Sources · Quetelet 1835 · Hutchinson 1846 · Hill 1923 · Framingham Heart Study 1976 · Gail et al., JNCI 1989 · Lip et al., Chest 2010 (CHA₂DS₂-VASc) · Hippisley-Cox et al., BMJ 2017 (QRISK3) · Horvath, Genome Biology 2013 · Levine et al., Aging 2018 (PhenoAge) · Lu et al., Aging 2019 (GrimAge) · Fong et al., npj Aging 2025 (LinAge2).
Pillar I · Disease
López-Otín et al. (Cell, 2023) mapped twelve molecular root causes of ageing. They are interconnected — chronic inflammation links all twelve — so targeting one cascade can slow many at once.
Sources · López-Otín et al., Cell 2023 · Nature, Immunosenescence and Inflammaging 2025.
Pillar II · Lifespan
The documented maximum is 122 years. Research suggests a biological ceiling of 120–150, set by loss of physiological resilience — not any single disease. The gap between average and ceiling is mostly environmental and behavioural, not genetic.
Sources · ONS Healthy Life Expectancy, UK, 2022–2024 · Health Foundation, April 2026 · Nature Aging 2024 · Institute for Health Metrics and Evaluation 2024.
Pillar III · Healthspan
The documented maximum is 122 — Jeanne Calment. The biological ceiling is estimated at 120–150 years. Clinic82's work is closing the space between where we are and where we can be.
Zone 2 cardio and resistance training can improve VO₂ max, one of the strongest predictors of long-term cardiovascular and all-cause mortality risk.
Time-restricted eating, protein optimisation and Mediterranean dietary patterns are associated with reduced late-life morbidity in observational and interventional studies.
Seven to nine hours. Poor sleep interacts with multiple ageing hallmarks and is associated with accelerated epigenetic ageing in longitudinal cohorts.
Strong social connection and a sense of life purpose are associated with meaningful gains in healthy life expectancy in multiple population studies.
Sources · Garmany & Terzic, Nature Communications Medicine 2025 · Columbia Mailman 2025.
The 82-organ-type framework
A person is not one system ageing at one rate. Kidneys, arteries, brain, pancreas — each has its own biological age, its own trajectory, its own set of dominant hallmarks.
The 82-organ-type framework — architected by Dr Oliver Zolman MBBS BSc, author of the Longevity Level 1–2–3 Protocol and Project Blueprint — maps the body as 82 organ types across 12 clinical domains. Each is measured, mapped against clinically relevant reference ranges and the patient’s individual trajectory, and given an intervention plan of its own. It is what makes a Clinic82 assessment more than a panel of bloods and a longevity brochure.
Ageing, addressed this way, becomes tractable — a set of local problems with local answers, not one abstract condition.
The framework maps 82 organ types across 12 clinical domains spanning male and female anatomy. Each patient is assessed across the organ types relevant to their anatomy, clinical history and individual requirements.
The 82-organ-type framework · Dr Oliver Zolman MBBS BSc · Longevity Level 1–2–3 Protocol · Project Blueprint.
The longevity circle
The clinicians and scientists defining the field — and the one Clinic82 works alongside.
Information theory of ageing; partial cellular reprogramming.
Discovered telomerase; telomere biology of ageing.
Creator of the epigenetic clock and GrimAge.
Centenarian genetics; leads the FDA TAME trial.
Defines Medicine 3.0 — ageing as the root disease.
Fasting-mimicking diet; autophagy and stem-cell renewal.
Architect of the 82-organ rejuvenation framework; lead doctor, Blueprint.
Clinic82 Clinical FrontierThe world's most measured human; open-sourced longevity data.
Referenced for scientific context. No affiliation, endorsement or formal relationship with Clinic82 is implied unless expressly stated — for example, Dr Oliver Zolman.
Sources · Morning Brew, Who's Who in Longevity 2024 · Life Biosciences / Sinclair Lab 2025.
The evidence
Two tiers. Where we act with confidence today, and where we watch the trials before we recommend.
Strongest evidence
The most validated human longevity intervention. Cardiorespiratory fitness predicts lifespan better than cholesterol.
Eight-to-ten hour eating windows reduce metabolic inflammation without strict calorie counting.
A diet-quality score built around foods shown to reduce chronic disease outcomes. Higher AHEI scores are inversely associated with all-cause, cardiovascular and cancer mortality across large multi-ethnic cohorts.
Restoring deep sleep and REM cycles is among the highest-leverage interventions in the biological ageing literature.
In clinical trials
Mechanism-of-action approaches to cellular ageing. Rapamycin (mTOR inhibition) confirmed safe in humans in the PEARL trial (2025). Senolytics (dasatinib+quercetin, fisetin) in Phase 2 across multiple age-related diseases. Neither is standard of care.
Beyond weight loss — reducing cardiovascular disease, chronic inflammation and Alzheimer's risk. Nature Biotechnology's pick for the first true longevity drug.
Yamanaka-factor cocktails reset epigenetic age in tissue; first-in-human trials began in 2026.
Sources · Mannick et al., Lancet Healthy Longevity 2025 · Nature Biotechnology 2025 · Lifespan.io 2025 · George et al., American Journal of Clinical Nutrition, 2014.
Zolman's Longevity Programmes
Lifespan — how long you live — is a real, measurable target. Healthspan — how many of those years you live well — is the target we intervene on. The Longevity Programmes at Clinic82 are built around measurable improvement in the second, delivered through disciplined intervention on the first.
Three residential longevity protocols — Alma, Zoé, Aión — read through the 82-organ-type framework. Built for people who are healthy, and want to stay that way.
Explore Longevity ProtocolsTailored, physician-led care for people already carrying a diagnosis — the Difficult Conditions care authored by Dr Dinos Xydas MD and his team.
Explore Difficult Condition Protocols